Product image of Montek (Sodium Molybdate (99mo)) supplied by GNH India

Montek

Active Ingredient:
Sodium Molybdate (99mo)
Origin:
EU

Montek (Sodium Molybdate (99mo))

Sodium molybdate, the active ingredient in Montek, is a mineral supplement presented as an injectable solution for intravenous and ocular use. It is employed to address molybdenum deficiency and to support enzymatic processes that require molybdenum as a cofactor.

GNH India supplies Montek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Monrol Europe Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Montek (sodium molybdate) is used in clinical settings that involve molybdenum‑dependent metabolic pathways.

  • Molybdenum deficiency: restores normal molybdenum levels and supports enzyme activity.
  • Wilson’s disease adjunct: may aid in copper metabolism modulation when used under specialist supervision.
  • Diagnostic imaging: employed as a contrast agent in certain hepatic function tests.

How It Works

  • Sodium molybdate supplies molybdenum ions that become incorporated into the active sites of molybdo‑enzymes such as xanthine oxidase, aldehyde oxidase and sulfite oxidase. By reconstituting these enzymes, the compound facilitates the oxidation of purines, aldehydes and sulfite, thereby supporting normal metabolic pathways and detoxification processes.

Side Effects

Sodium molybdate may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild gastrointestinal discomfort.
  • Headache: transient cranial pain.
  • Injection site pain: local tenderness or erythema.
  • Dizziness: temporary light‑headedness.
  • Transient hypotension: brief drop in blood pressure.

Serious or Rare Side Effects

  • Anaphylactic reaction: severe allergic response requiring immediate medical attention.
  • Severe hypersensitivity: rash, swelling, or bronchospasm.
  • Renal impairment: elevated creatinine or reduced kidney function.
  • Hepatotoxicity: abnormal liver enzymes.
  • Hemolysis: destruction of red blood cells.

Precautions & Warnings

When using Montek, several precautions should be observed to ensure patient safety and product integrity.

  • Renal function monitoring: assess serum creatinine before and during therapy.
  • Hepatic assessment: evaluate liver enzymes in patients with pre‑existing liver disease.
  • Allergy screening: avoid use in individuals with known hypersensitivity to molybdenum compounds.
  • Pregnancy consideration: use only if the potential benefit justifies the potential risk to the fetus.
  • Concomitant copper therapy: monitor copper levels as molybdenum may interfere with copper metabolism.
  • Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Sodium molybdate can interact with other substances, influencing its safety and efficacy.

Major Interactions (Avoid)

  • High‑dose copper supplements: may precipitate copper deficiency and exacerbate toxicity.
  • Other molybdenum preparations: combined use can lead to molybdenum overload and toxicity.

Moderate Interactions (Monitor Closely)

  • Drugs metabolized by molybdo‑enzymes (e.g., certain antivirals): potential alteration of drug clearance.
  • Vitamin B12 therapy: molybdenum may affect B12 absorption.
  • Anticoagulants: monitor coagulation parameters as molybdenum can influence platelet function.

Frequently Asked Questions

Montek contains sodium molybdate, which is primarily used to correct molybdenum deficiency and to support metabolic pathways that rely on molybdenum‑dependent enzymes. It may also be employed as an adjunct in conditions such as Wilson’s disease and in certain diagnostic imaging procedures that require a molybdenum‑based contrast agent.

Sodium molybdate provides molybdenum ions that become part of the active sites of molybdo‑enzymes like xanthine oxidase, aldehyde oxidase and sulfite oxidase. Restoring these enzymes enables normal oxidation of purines, aldehydes and sulfite, which are essential steps in detoxification and energy metabolism.

The dosage of Montek is individualized. A qualified prescriber determines the appropriate amount, frequency and duration based on the patient’s clinical condition, laboratory values and response to therapy. No standard dosing regimen is provided in public literature.

Safety data for sodium molybdate during pregnancy and lactation are limited. It should only be used when the potential therapeutic benefit outweighs any possible risk to the fetus or infant, and this decision must be made by the treating physician.

To request Montek, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and the necessary import documentation.

Montek is formulated as an injectable solution for intravenous and ocular administration, offering rapid systemic availability compared with oral molybdenum salts. This route can be advantageous in acute deficiency or when precise dosing is required, whereas oral preparations are generally used for chronic supplementation.

Montek should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and direct sunlight. The container must remain sealed until use, and any unused portion should be discarded according to local regulations for pharmaceutical waste.

Montek is administered by a qualified healthcare professional either as an intravenous infusion or as an ocular injection, depending on the therapeutic indication. The exact technique, infusion rate and volume are determined by the prescriber and follow standard aseptic procedures.

The most critical safety concerns include severe hypersensitivity reactions such as anaphylaxis, renal impairment manifested by rising creatinine levels, and hepatotoxicity indicated by abnormal liver enzymes. Immediate medical attention is required if any signs of these serious adverse events appear.

Montek is contraindicated in individuals with known hypersensitivity to sodium molybdate or any component of the formulation. Patients with severe renal or hepatic dysfunction should avoid its use unless a specialist determines that benefits outweigh the risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Molybdate (99mo)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT